BIODEXA PHARMACEUTICALS-ADR
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BIODEXA PHARMACEUTICALS-ADR ADR, CUSIP 59564R302.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for BIODEXA PHARMACEUTICALS-ADR ADR, CUSIP 59564R302.